Expanding Horizons in Peptide Innovation _ A New Era of Production Excellence at Smartox_SB-PEPTIDE

For over 10 years, Smartox Biotechnology and its subsidiary SB-PEPTIDE have specialized in peptide research and production. As a recipient of the France 2030 Recovery Plan and with strong local support, the group has just moved into a new facility that will enable it to triple its production capacity and manufacture pharmaceutical active ingredients for clinical trials (manufactured under GMP conditions, including a clean room).

On July 10, 2023, Smartox inaugurated this new building, marking a key milestone in our development. Designed to enhance production capacity and ensure compliance with Good Manufacturing Practices (GMP), the site is partially funded by the French government through the national recovery plan. This governmental support signifies a strong commitment to innovation and industrial sovereignty. With this new facility, Smartox can scale up peptide production to meet the growing demands of the pharmaceutical industry.

For more details on the event, visit the publication on our SB-Peptide website:

https://www.sb-peptide.com/about/news-events/sb-peptide-premises-inauguration-isere/

Smartox custom peptide services

Disclosed peptide toxins and others are available upon request. Feel free to browse our product catalog or contact us for project evaluation.

Products

contact@smartox-biotech.com